IPAR vs XRAY · P/E 17, rev $1.32B vs rev $3.68B
Inter Parfums Inc (IPAR) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Inter Parfums Inc (IPAR) is a household & personal products company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported IPAR revenue for 2023-12-31 was $1.32B. Net income was $187.8M. Revenue was up 21.3% from 2022-12-31 to 2023-12-31. IPAR currently screens at market cap $2.92B and trailing P/E 17.3.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
IPAR currently screens at market cap $2.92B and trailing P/E 17.3. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the IPAR and XRAY stock pages for the full models.
Not investment advice.